Chronic Lymphocytic Leukemia (CLL) Patients Quality of Life (QoL): A Cross-Sectional Analysis of the Italian Experience in the Choice Study during the First Wave of the COVID-19 Pandemic

Introduction Although plenty of data exists on efficacy and safety of CLL drugs, their impact on patients' Health-Related Quality of Life (HRQoL) is largely unknown (1-2). Documentation of drug safety via traditional use of adverse events (AE) in hematology is limited if not complemented with P...

Descripción completa

Detalles Bibliográficos
Autores principales: Tedeschi, Alessandra, Innocenti, Idanna, Albano, Francesco, Gozzetti, Alessandro, Levato, Luciano, Porrazzo, Marika, Reda, Gianluigi, Albi, Elisa, Chiarenza, Annalisa, Gualberti, Giuliana, Malgieri, Simona, Finsinger, Paola, Trentin, Livio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
642.Chronic Lymphocytic Leukemia: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342888/
http://dx.doi.org/10.1182/blood-2021-150274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342888/
http://dx.doi.org/10.1182/blood-2021-150274

Ejemplares similares